B Cell Activity Is Impaired in Human and Mouse Obesity and Is Responsive to an Essential Fatty Acid upon Murine Influenza Infection

Copyright © 2017 by The American Association of Immunologists, Inc..

Obesity is associated with increased risk for infections and poor responses to vaccinations, which may be due to compromised B cell function. However, there is limited information about the influence of obesity on B cell function and underlying factors that modulate B cell responses. Therefore, we studied B cell cytokine secretion and/or Ab production across obesity models. In obese humans, B cell IL-6 secretion was lowered and IgM levels were elevated upon ex vivo anti-BCR/TLR9 stimulation. In murine obesity induced by a high fat diet, ex vivo IgM and IgG were elevated with unstimulated B cells. Furthermore, the high fat diet lowered bone marrow B cell frequency accompanied by diminished transcripts of early lymphoid commitment markers. Murine B cell responses were subsequently investigated upon influenza A/Puerto Rico/8/34 infection using a Western diet model in the absence or presence of docosahexaenoic acid (DHA). DHA, an essential fatty acid with immunomodulatory properties, was tested because its plasma levels are lowered in obesity. Relative to controls, mice consuming the Western diet had diminished Ab titers whereas the Western diet plus DHA improved titers. Mechanistically, DHA did not directly target B cells to elevate Ab levels. Instead, DHA increased the concentration of the downstream specialized proresolving lipid mediators (SPMs) 14-hydroxydocosahexaenoic acid, 17-hydroxydocosahexaenoic acid, and protectin DX. All three SPMs were found to be effective in elevating murine Ab levels upon influenza infection. Collectively, the results demonstrate that B cell responses are impaired across human and mouse obesity models and show that essential fatty acid status is a factor influencing humoral immunity, potentially through an SPM-mediated mechanism.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:198

Enthalten in:

Journal of immunology (Baltimore, Md. : 1950) - 198(2017), 12 vom: 15. Juni, Seite 4738-4752

Sprache:

Englisch

Beteiligte Personen:

Kosaraju, Rasagna [VerfasserIn]
Guesdon, William [VerfasserIn]
Crouch, Miranda J [VerfasserIn]
Teague, Heather L [VerfasserIn]
Sullivan, E Madison [VerfasserIn]
Karlsson, Erik A [VerfasserIn]
Schultz-Cherry, Stacey [VerfasserIn]
Gowdy, Kymberly [VerfasserIn]
Bridges, Lance C [VerfasserIn]
Reese, Lauren R [VerfasserIn]
Neufer, P Darrell [VerfasserIn]
Armstrong, Michael [VerfasserIn]
Reisdorph, Nichole [VerfasserIn]
Milner, J Justin [VerfasserIn]
Beck, Melinda [VerfasserIn]
Shaikh, Saame Raza [VerfasserIn]

Links:

Volltext

Themen:

10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid
14-hydroxydocosahexaenoic acid
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid
25167-62-8
86360-66-9
90780-52-2
Docosahexaenoic Acids
Fatty Acids, Essential
Immunoglobulin M
Interleukin-6
Journal Article
TLR9 protein, human
Toll-Like Receptor 9

Anmerkungen:

Date Completed 27.09.2017

Date Revised 02.12.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.4049/jimmunol.1601031

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM271850019